Gene therapy for wet AMD wins fast track designation

• Posted on: Sep 24 2018
• By: Saratoga Opthalmology
• Leave a response

The FDA awarded fast track designation to a single-administration, intravitreal gene therapy for wet AMD, according to a press release by Adverum Biotechnologies.
Source: AAO

Posted in: Uncategorized